Imprinted genes in which only one of the two parental chromosome copies is expressed have a substantial effect on mammalian ontogenesis. On mouse distal chromosome 7, the paternally expressed gene insulin-like growth factor 2 (Igf2) is separated by approximate 100 kb from the maternally expressed non-coding gene H19. However, there is limited knowledge of the manner in which Igf2 transcription affects the other genes involved in embryonic development. To clarify this, we performed quantitative gene expression analysis for representative angiogenic factors- Vegf, Flt1, Flt4, Flk1, Ang1, Ang2, Tie1, and Tie2-for 3 types of bi-maternal conceptuses containing genomes with non-growing (ng) and fully grown (fg) oocytes. The genetic backgrounds of the ng oocytes were 1) the wild type (ng wt ), 2) mutant mice carrying a 3-kb deletion of the H19 transcription unit (ng H19Δ3-KO /fg) and 3) mutant mice carrying a 13-kb deletion in the H19 transcription unit, including the germline-derived differentially methylated region on chromosome 7 (ng H19Δ13-KO /fg). In the ng wt /fg and ng H19Δ3-KO /fg placentae, Vegf and Flt1 were upregulated compared with the mean value for the wt placenta, whereas in the ng H19Δ13-KO /fg placenta, these transcriptional levels were restored. In the fetus, however, only 2 genes among the 8 genes analyzed were significantly changed in the bi-maternal fetuses, indicating that the effects of the Igf2 mRNA level on angiogenic factor transcription in the fetus differed from those in the placenta. Our results indicated that the Igf2 mRNA level affects transcription of angiogenic factors in both bi-maternal placentae and fetuses. Key words: Angiogenic factors, Mouse, H19, Insulin-like growth factor 2 (Igf2), Serial nuclear transfer (J. Reprod. Dev. 56: [79][80][81][82][83][84][85] 2010) enomic imprinting, whereby certain genes exhibit parental origin-specific expression, is a critical control mechanism in embryonic development of mammals, as it inhibits parthenogenesis by ensuring that genes from both parents are functionally present. Therefore, genomic imprinting is essential for normal ontogeny, and imprinted genes are regulated by epigenetic modifications, including DNA methylation. Acquisition of methylation occurs in each parental germline during male or female gametogenesis [1, 2] . Most imprinted genes are regulated by maternally-derived methylation, while only three regions on mouse chromosomes 7, 9 and 12 have been identified as genes regulated by paternally-derived methylation [3] .
(J. Reprod. Dev. 56: 79-85, 2010) enomic imprinting, whereby certain genes exhibit parental origin-specific expression, is a critical control mechanism in embryonic development of mammals, as it inhibits parthenogenesis by ensuring that genes from both parents are functionally present. Therefore, genomic imprinting is essential for normal ontogeny, and imprinted genes are regulated by epigenetic modifications, including DNA methylation. Acquisition of methylation occurs in each parental germline during male or female gametogenesis [1, 2] . Most imprinted genes are regulated by maternally-derived methylation, while only three regions on mouse chromosomes 7, 9 and 12 have been identified as genes regulated by paternally-derived methylation [3] .
We have previously analyzed mouse conceptuses derived from only maternal genomes that carry two sets of haploid genomes from non-growing (ng) and fully grown (fg) oocytes, which are able to develop to embryonic day (E) 13.5 [4] [5] [6] . In these embryos, the paternally expressed genes, Peg1/Mest, Peg3 and Snrpn, were activated, while the maternally expressed genes, Igf2r and p57Kip2, were silent in the alleles derived from a non-growing oocyte genome [6, 7] . Hence, on theoretical grounds, all of the imprinted gene transcriptions regulated by maternal-methylation imprinting could be corrected in bi-maternal ng/fg embryos. However, paternally methylated imprinted genes containing the H19 and Igf2 genes have not been altered in the ng allele [4, 5, 8] .
Chromosome 7 contains one protein-coding gene expressed by the paternally inherited chromosome, insulin-like growth factor 2 (Igf2); on the maternally inherited chromosome, this gene is repressed, and a non-coding RNA transcript, H19, is expressed ( Fig. 1 ) [9] [10] [11] . The Igf2 gene, which encodes a growth-promoting factor (IGF2), is well known as a primary regulator of fetal growth [12] [13] [14] . In ng wt /fg embryos derived from wild-type ng oocytes, H19 is biallelically expressed, while Igf2 is repressed, as the enhancers that are shared by Igf2 and H19 act preferentially on H19 on both chromosomes (Fig. 1) [5] . Furthermore, mutated ng oocyte genomes that mimic paternal function at chromosome 7 allow us to analyze bi-maternal ng/fg conceptuses after E13.5; specifically, one harbors a 3-kb deletion of the H19 transcription unit (H19
Δ3
), and the other harbors a 13-kb deletion containing the differentially methylated region and the H19 transcription unit (H19
Δ13
) [8, 15] . The ng H19Δ3-KO /fg bi-maternal conceptuses with monoallelic H19 expression are able to develop to E17.5 with a leakage level of Igf2 expression [15] ; additionally, they show further extended development to E19.5 with corrected expression patterns for both the H19 and Igf2 genes ( Fig. 1) [4, 8] .
Nevertheless, the ng H19Δ3-KO /fg and ng H19Δ13-KO /fg bi-maternal conceptuses also form placentae concomitantly with a malformed labyrinthine layer and anomalous circulatory system [15, 16] . The labyrinth plays a crucial role in the exchange of nutrients, gases and waste between maternal and fetal blood, and its vasculature is one of the most important factors supporting fetal viability. Histological analysis of the ng H19Δ3-KO /fg placenta has shown that severe necrosis occurs throughout the tissue, particularly in the labyrinthine layer [15] . Moreover, scanning electron microscopy studies of casts have definitively shown that in ng H19Δ13-KO /fg placentae, both the maternal sinusoids and fetal blood vessels within the labyrinth are defective [16] . However, the vasculature in the ng H19Δ13-KO /fg placenta is clearly improved compared with the ng wt /fg placenta; the mechanism by which this occurs has yet to be elucidated fully.
Generally, IGF2 action can affect the growth of the fetus; overexpression of Igf2 can increase the size at birth up to 160% [17] and the size at E17 up to 200% [18] in a dose-dependent manner. In human hepatocellular carcinomas cells, it is known that hypoxiainduced vascular endothelial growth factor (VEGF) expression [19] is increased by IGF2. VEGF plays a role in formation of new blood vessels from preexisting ones. The regulatory pathways for insulin-induced angiogenesis have been investigated in human umbilical venous endothelial cells [20] , and IGF2 may be implicated in several aspects of placental development, including blood vessel formation. Meanwhile, the targets of H19 remain to be identified, although several studies have been conducted to understand the biological function of H19 mRNA using mutant mice harboring the deletion of the H19 transcription unit [13, 21] and overexpressing H19 mRNA [22] . To date, there has been no definite evidence that H19 transcription is positively involved in vascular formation during the developmental period in mice.
In this study, to clarify the contributions of Igf2 mRNA expression to mouse ontogenic angiogenesis, we conducted a thorough investigation of the transcriptional levels of 8 representative angiogenic factors-Vegf, Flt1, Flt4, Flk1, Ang1, Ang2, Tie1 and Tie2-in 3 bi-maternal conceptus models, the ng wt /fg, ng H19Δ3-KO /fg and ng H19Δ13-KO /fg genotypes. These bi-maternal conceptuses exhibit varying Igf2 mRNA expression levels. In ng wt /fg conceptuses, Igf2 mRNA expression is repressed, whereas the ng H19Δ3-KO /fg conceptuses exhibit Igf2 mRNA expression at a leakage level [5, 15] . On the other hand, the Igf2 transcription levels in the ng H19Δ13-KO /fg conceptuses are close to wild-type levels [8] . Vegf is a potent inducer of angiogenesis. This is necessary for tissue development and promotes tumor growth [23, 24] . Flt1, Flt4 and Flk1 are a set of mammalian tyrosine kinase receptors for Vegf that exhibit important regulatory functions in the formation of new blood vessels during embryonic vasculogenesis [24, 25] . The angiopoietin ligand (Ang1 and Ang2) and Tie receptor families (Tie1 and Tie2) are also important regulators of blood vessel growth, maturation, and function [26] . We report here that the transcription levels of the Igf2 gene affect the mRNA expression levels of these angiogenic factors.
Materials and Methods

Production of ng/fg bi-maternal conceptuses
Serial nuclear transfer was carried out as outlined previously [27] . Ng oocytes (ng H19Δ3-KO /fg or ng H19Δ13-KO /fg) containing a haploid set of genome H19 Δ3 or H19 Δ13 mutant females, as well as a genome obtained from ovulated MII oocytes of wild-type B6D2F1 mice, were constructed by nuclear transfer. Fusion of the diplotene oocytes with enucleated oocytes at the germinal vesicle stage (GV) was induced with an inactivated Sendai virus (HVJ, 2700 hemagglutinating activity units/ml). After fusion, the reconstituted oocytes were cultured for 14 h in α-MEM medium (GIBCO, Grand Island, NY, USA). The GV oocytes were manipulated in a medium containing 200 μM dbcAMP and 5% calf serum throughout the experiment and were released from the medium 1 h after fusion with a non-growing stage oocyte. A set of MII chromosomes from reconstituted oocytes was transferred into an enucleated MII oocyte that had been collected from the oviducts of superovulated B6D2F1 mice 15-16 h after hCG injection. ng wt /fg bi-maternal embryos were also produced from wild-type B6D2F1 mice as described above. The reconstructed oocytes were artificially activated with 10 mM SrCl2 in Ca 2+ -free M16 medium for 2 h. These embryos were cultured in M16 medium for 3.5 days in an atmosphere of 5% CO2, 5% O2 and 90% N2 at 37 C [28] . The embryos that developed to the blastocyst stage were transferred into the uterine horns of recipient female mice at 2.5 days of pseudopregnancy. The fetuses and placentae were recovered from the pregnant mice at E12.5 and used in the subsequent analyses as in our previous studies [16, 29] .
Quantitative gene expression analysis
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN, Tokyo, Japan) from four types of whole fetuses and placentae, wild-type (wt; n=3) and bi-maternal conceptuses derived from ng wt / fg (n=5), ng H19Δ3-KO /fg (n=5) and ng H19Δ13-KO /fg (n=4) embryos. Using ISOGEN (Nippon Gene, Tokyo, Japan), total RNA was isolated from the fetuses and placentae at E12.5. After total RNA was treated with DNase (Promega, Madison, WI, USA) to exclude the genomic DNA, the absence of genomic DNA contamination was confirmed by the lack of amplification of GAPDH by PCR. The cDNAs were then synthesized using a SuperScript TM II RnaseH reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) in a reaction solution (20 μl) containing total RNA (1 μg) prepared from each placenta. Finally, quantitative analysis of gene expression was performed using real-time PCR (LightCyclerTM System, Roche Molecular Biochemicals, Mannheim, Germany) after preparing the reaction mixture (LightCycler FastStart DNA Master SYBR Green I, Roche Molecular Biochemicals). The primers used for the analysis are listed in Table 1 .
Statistical analyses
Statistical analyses of all data for comparison to wild-type controls were carried out using one-way analysis of variance (ANOVA) and the Fisher PLSD test using the statistical analysis software StatView (Abacus Concepts, Berkeley, CA, USA). A P value of <0.05 was considered statistically significant.
Results
Confirmation of the mRNA expression levels of Igf2 and H19 in bi-maternal conceptuses
To confirm the mRNA expression levels of Igf2 and H19 in the bi-maternal conceptuses used in this study, we first analyzed the mRNA levels of these two genes in individual wt, ng wt /fg, (Fig. 2) . As expected, the results were consistent with our previous reports in regard to the Igf2 mRNA levels; specifically, the expressions of both genes were repressed in the ng wt /fg conceptuses and expressed at leakage levels in the ng H19Δ3-KO /fg conceptuses [5, 15] . In the ng H19Δ13-KO /fg conceptuses, the Igf2 mRNA levels were fully restored [8, 16] . However, the H19 gene was not theoretically expressed in all of the bi-maternal conceptus types. We do not have a clear explanation for this finding at the moment; however, the quantitative expression analysis was carried out correctly. We have observed a smilar phenomenon, a lack of theoretical expression of non-coding RNAs such as H19, in previous studies [8, 16, 29, 30] . However, the results confirm that these bi-maternal conceptuses can be used to explore the effects of Igf2 mRNA levels on transcription of the other genes in the mouse placenta and fetus.
Transcription levels of angiogenic factors in bi-maternal placenta
We performed quantitative gene expression analysis for the Vegf, Flt1, Flt4, Flk1, Ang1, Ang2, Tie1 and Tie2 genes in individual wt, ng wt /fg, ng H19Δ3-KO /fg and ng H19Δ13-KO /fg placentae using real-time PCR (Fig. 3 ). There were no significant differences in Flk1, Ang2 and Tie2 transcription between any of the bi-maternal placentae or the wt placenta. The expressions of Vegf and Flt1 were corrected in the ng H19Δ13-KO /fg placenta, but not in the other placentae (Fig 3; † † double daggers). In the ng wt /fg and ng H19Δ3-KO / fg placentae, both of these RNAs were upregulated compared with the mean values in the wt placenta. The Flt4 and Tie1 RNA expression levels remained elevated in all of the bi-maternal placentae ( Fig. 3; † single dagger). Interestingly, Ang1 RNA expression was corrected in the ng H19Δ3-KO /fg and ng H19Δ13-KO /fg placentae, but not in the ng wt /fg placenta. Thus, we confirmed that alteration of the Igf2 mRNA expression level can affect transcription levels of angiogenic factors in mouse placentae.
Transcription levels of angiogenic factors in the bi-maternal fetus
To gain further understanding of the transcription levels of angiogenic factors in bi-maternal conceptuses, we also carried out quantitative gene expression analysis in fetuses, as was conducted for the placenta (Fig. 4) . Unlike the placenta, Vegf mRNA expression in the fetus was upregulated only in the ng wt /fg conceptus ( Fig.  4; † † † triple daggers). The Flt1 transcription level in the fetus was also elevated in the ng wt /fg and ng H19Δ3-KO /fg conceptuses ( Fig. 4 ; † single dagger). However, the transcription levels of Flt4, Ang1 and Tie1 in all the bi-maternal fetuses were not statistically different from those in the wt fetus. These results suggest that, in the bimaternal fetus, the Igf2 mRNA expression level may affect the transcription levels of angiogenic factors via mechanisms distinct from those in the placenta.
Discussion
While the embryonic vascular system develops in anticipation of the demands of the growing embryo for oxygen and nutrients, angiogenesis in the organism occurs in response to the metabolic requirements of tissues and is efficiently triggered by hypoxia [24] . A variety of diseases are associated with either insufficient or excess blood vessel growth. Furthermore, adaptation of the maternal uterine vasculature is also essential for normal fetal and placental development, during which angiogenesis is considered one of the most critical adaptive changes. The process of placental vasculogenesis/angiogenesis requires tight orchestration between vascular endothelial cell-specific ligands and their tyrosine kinase receptors. These include the Vegf family members, including placental growth factor and the angiopoietins, primarily Ang1 and Ang2 [31] . Lack of appropriate function of one or more of these molecules and/or their receptors may adversely affect pregnancy outcome. Meanwhile, genes undergoing the phenomenon of genomic imprinting are also involved in regulation of major functions at the feto-maternal interface, such as nutrient transport, trophoblast proliferation, invasion and angiogenesis [32] [33] [34] . We have previously observed that vasculature in bi-maternal placentae with corrected imprinted genes regulated by the Igf2-H19 domain on chromosome 7 is relatively improved compared with bi-maternal placentae that lack the ability to mimic the expression pattern of the paternal chromosome [16] . However, there is only a limited understanding of the manner in which the Igf2 mRNA expression level contributes to vasculogenesis/angiogenesis in mouse conceptuses.
Propagating effects of imprinted genes controlled by the Igf2-H19 domain on angiogenic factor transcription in the placenta
The present study demonstrates that transcription levels of angiogenic factors in the bi-maternal mouse placenta can be affected in an Igf2 mRNA level-dependent manner. Only ng H19Δ13-KO /fg placenta from among the bi-maternal placentae analyzed had the Vegf and Flt1 mRNA expression levels that were corrected to those of the wild-type placenta, suggesting that appropriate transcription levels of these angiogenic factors are moderately dependent on the Igf2 mRNA expression level in the placenta (Figs. 3 and 5) . In contrast, the ng H19Δ3-KO /fg placenta with a leakage level of Igf2 mRNA expression exhibited anomalously elevated Vegf and Flt1 mRNA levels. Although the direct association between Igf2 and such angiogenic factors is not fully understood, we have previously observed impaired vasculogenesis in the ng wt /fg placenta and the ng H19Δ3-KO /fg placenta [15, 16] . In these bi-maternal placentae, severe ischemic necrosis was observed throughout the placental tissues, suggesting that this placental defect causes hypoxidosis and metabolic defects. Our results imply that placental hypoxia occurs in bi-maternal conceptuses when Igf2 mRNA is not sufficiently expressed.
Hypoxia is known to be a potent stimulus for expression of Vegf and Flt1, and these mRNAs have been shown to be upregulated by hypoxia in a variety of cell types; their increase is thought to be a major mechanism triggering hypoxia-induced angiogenesis [35] [36] [37] . However, the growth of capillaries in the ng H19Δ3-KO /fg placenta was not sufficient to completely recuperate from hypoxia symptoms, and therefore, Flt4 mRNA was overexpressed under hypoxic conditions in all of the bi-maternal placentae, suggesting that appropriate transcription from paternally methylated imprinted genes on chromosome 12 is required to complete definitive placentation [16, 38] . Tie1 mRNA was also overexpressed in all the bimaternal placentae.
The angiopoietin-Tie2 system also plays a key role in vessel remodeling, maturation and stabilization in vasculogenesis/angiogenesis. Tie1 and Tie2 belong to a subfamily of vascular tyrosine kinase receptors expressed predominantly in endothelial cells, whose ligands are Ang1 and Ang2 [39, 40] . In endothelial cells, Ang1 induces Tie2 phosphorylation [41] ; Ang2 inhibits Ang1-induced Tie2 activation unless endothelial cells undergo prolonged exposure to higher concentrations of Ang2. Targeted Tie1 disruption results in embryonic lethality due to edema, hemorrhage and microvessel rupture [42] [43] [44] . Tie1-deficient embryos contain hyperactive endothelial cells exhibiting a large number of extensions and filopodia projecting into the vessel lumen and have increased capillary densities, suggesting that Tie1 may act as a brake during embryonic angiogenesis [44] . Overexpression of Tie1 mRNA in the bi-maternal placenta may have resulted in their poorly developed vasculature. In the ng H19Δ3-KO /fg and ng H19Δ13-KO / fg placentae, the Ang1 transcription level was restored, indicating that appropriate transcription of this gene is highly sensitive to the Igf2 mRNA expression level.
Differential effects of Igf2 and H19 mRNA expression on angiogenic factor transcription in the fetus and placenta
In addition to placentae, we also carried out quantitative gene expression analysis in bi-maternal fetuses (Fig. 4) . In contrast to the results for the placentae, only 2 genes among the 8 genes analyzed were significantly affected in the bi-maternal fetuses. Flt1 mRNA expression was corrected in the ng H19Δ3-KO /fg fetus; however, this result was unexpected because Flt1 transcription in the ng H19Δ13-KO /fg fetus was not restored. We do not have a clear explanation for this finding. Interestingly, the Vegf mRNA expression levels in both the ng H19Δ3-KO /fg and ng H19Δ13-KO /fg fetuses were generally the same as in the wt fetus, but not in the ng wt /fg fetus. This phenomenon was entirely different from the result obtained by quantitative gene expression analysis for the placenta, indicating an evident difference in the effects on angiogenic factor transcription between the placenta and the fetus (Fig. 5) . Our results appear to be consistent with a previous report indicating that placental phenotype depends on the interplay between placental and fetal Igf2 in the mouse [45] . Previously, the reason for death of ng H19Δ3-KO /fg conceptuses at E17.5 was unclear, but we hypothesized that defects in the placenta, rather than in the fetus itself, were the main reason for lethality based on a histological assessment [15] . The present study confirms the above hypothesis concerning the differential propagating effects of the Igf2 mRNA expression level.
To explore the manner in which the Igf2 mRNA expression level contributes to vasculogenesis/angiogenesis in the bi-maternal placenta and fetus, we performed quantitative gene expression analysis on 8 representative angiogenic factors-Vegf, Flt1, Flt4, Flk1, Ang1, Ang2, Tie1 and Tie2-in 3 types of bi-maternal placentae and fetuses, ng wt /fg, ng H19Δ3-KO /fg and ng H19Δ13-KO /fg genotypes. In the bi-maternal conceptuses, we demonstrated that transcription levels of angiogenic factors could be altered in an Igf2 mRNA expression dose-dependent manner and further found that the propagating effects on the transcription levels of angiogenic factors are different between the placenta and the fetus (Fig. 5) . Thus, studying bi-maternal conceptuses provides further insights into the mechanisms by which paternally methylated imprinted genes containing Igf2 regulate mammalian ontogenesis. 
